| |
| |
|
| Insider
Information: |
Fenimore Christopher R. |
| Relationship: |
SVP Finance & CFO |
| City: |
Tarrytown |
| State: |
NY |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
14,372 |
|
|
Indirect Shares
|
10,059 |
|
|
| Direct
Value |
$14,156,707 |
|
|
|
Indirect Value
|
$9,908,316 |
|
|
| Total
Shares |
24,431 |
|
|
| Total
Value |
$24,065,024 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
1
|
|
Stock
price went up :
|
0
|
1
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
1.0
|
| Percentage
Gain/Loss : |
0.0%
|
 2.9%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Regeneron Pharmaceuticals Inc |
REGN |
SVP Finance & CFO |
2024-02-09 |
14,372 |
2024-02-09 |
10,059 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
66 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 3 of 3
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| REGN |
Regeneron Pharmaceuticals... |
VP Controller |
• – – |
2019-01-18 |
4 |
OE |
$21.25 |
$3,188 |
D/D |
150 |
7,246 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
VP Controller |
• – – |
2019-04-18 |
4 |
OE |
$21.25 |
$7,438 |
D/D |
350 |
7,446 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
VP Controller |
• – – |
2019-12-12 |
4 |
OE |
$52.03 |
$161,293 |
D/D |
3,100 |
15,297 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
VP Controller |
• – – |
2019-12-20 |
4 |
OE |
$30.63 |
$12,252 |
D/D |
400 |
12,597 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
VP Controller |
• – – |
2020-01-24 |
4 |
OE |
$30.63 |
$15,315 |
D/D |
500 |
13,097 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
VP Controller |
• – – |
2020-04-01 |
4 |
OE |
$30.63 |
$36,756 |
D/D |
1,200 |
14,297 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
VP Controller |
• – – |
2020-06-15 |
4 |
OE |
$30.63 |
$442,742 |
D/D |
9,406 |
18,833 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
VP Controller |
• – – |
2020-07-20 |
4 |
OE |
$52.03 |
$1,907,015 |
D/D |
12,224 |
21,210 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
SVP Controller |
• – – |
2021-08-20 |
4 |
OE |
$179.13 |
$2,418,255 |
D/D |
13,500 |
32,520 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
SVP Controller |
• – – |
2022-03-31 |
4 |
OE |
$270.43 |
$3,815,640 |
D/D |
12,000 |
31,628 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
SVP Controller |
• – – |
2022-04-08 |
4 |
OE |
$270.43 |
$2,713,542 |
D/D |
7,450 |
30,066 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
SVP Controller |
• – – |
2023-02-03 |
4 |
OE |
$270.43 |
$1,352,150 |
D/D |
5,000 |
23,581 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
SVP Controller |
• – – |
2023-08-23 |
4 |
OE |
$399.66 |
$2,797,620 |
D/D |
7,000 |
26,140 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
SVP Controller |
• – – |
2024-01-03 |
4 |
OE |
$399.66 |
$4,776,650 |
D/D |
10,000 |
20,329 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
SVP Controller |
• – – |
2024-01-23 |
4 |
OE |
$399.66 |
$4,776,650 |
D/D |
10,000 |
22,874 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
SVP Finance & CFO |
• – – |
2024-02-09 |
4 |
S |
$950.49 |
$4,689,320 |
D/D |
(4,919) |
14,372 |
0 |
% |
|
66 Records found
|
|
Page 3 of 3 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
